N1-(4-(1,5,9-triazacyclododecan-1-yl)butyl)butane-1,4-diamine

ID: ALA5084961

PubChem CID: 166635235

Max Phase: Preclinical

Molecular Formula: C17H44Cl5N5

Molecular Weight: 313.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cl.Cl.Cl.Cl.Cl.NCCCCNCCCCN1CCCNCCCNCCC1

Standard InChI:  InChI=1S/C17H39N5.5ClH/c18-8-1-2-9-19-10-3-4-15-22-16-6-13-20-11-5-12-21-14-7-17-22;;;;;/h19-21H,1-18H2;5*1H

Standard InChI Key:  CSTKMKJDQDFPNF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 22  0  0  0  0  0  0  0  0999 V2000
   26.1835   -1.0000    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   18.3084   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0230   -4.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5939   -4.7167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7374   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4519   -4.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1664   -5.1292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8808   -4.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5953   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3098   -4.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0242   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7387   -4.7167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4485   -5.1301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7322   -3.8918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4508   -3.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8845   -2.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1715   -2.2489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4515   -2.6573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1631   -4.7208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8701   -5.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5811   -4.7198    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5805   -3.8992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8690   -3.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9002   -1.4083    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   29.1210   -3.9083    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   26.0877   -6.2500    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.9960   -6.1583    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 13 19  1  0
 15 14  1  0
 15 18  1  0
 23 16  1  0
 16 17  1  0
 17 18  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
M  END

Associated Targets(Human)

L3.6pl (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 313.53Molecular Weight (Monoisotopic): 313.3205AlogP: 0.76#Rotatable Bonds: 9
Polar Surface Area: 65.35Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.01CX LogP: -0.54CX LogD: -10.08
Aromatic Rings: Heavy Atoms: 22QED Weighted: 0.47Np Likeness Score: -0.32

References

1. Dobrovolskaite A, Gardner RA, Delcros JG, Phanstiel O..  (2022)  Development of Polyamine Lassos as Polyamine Transport Inhibitors.,  13  (2.0): [PMID:35178189] [10.1021/acsmedchemlett.1c00557]

Source